News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,677 Results
Type
Article (62412)
Company Profile (77)
Press Release (604179)
Multimedia
Podcasts (102)
Webinars (21)
Section
Business (174177)
Career Advice (2749)
Deals (32534)
Drug Delivery (116)
Drug Development (77170)
Employer Resources (154)
FDA (15158)
Job Trends (13947)
News (306023)
Policy (29155)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2910)
Academic (2)
Accelerated approval (33)
Adcomms (28)
Allergies (142)
Alliances (43311)
ALS (167)
Alzheimer's disease (1599)
Antibody-drug conjugate (ADC) (290)
Approvals (15432)
Artificial intelligence (528)
Autoimmune disease (160)
Automation (37)
Bankruptcy (291)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (176)
Biotechnology (55)
Bladder cancer (154)
Brain cancer (60)
Breast cancer (625)
Cancer (4695)
Cardiovascular disease (392)
Career advice (2347)
Career pathing (40)
CAR-T (288)
CDC (45)
Celiac Disease (2)
Cell therapy (764)
Cervical cancer (35)
Clinical research (66070)
Collaboration (1649)
Company closure (5)
Compensation (713)
Complete response letters (56)
COVID-19 (2683)
CRISPR (93)
C-suite (900)
Cystic fibrosis (144)
Data (6107)
Decentralized trials (2)
Denatured (41)
Depression (132)
Diabetes (471)
Diagnostics (6468)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (246)
Drug pricing (185)
Drug shortages (25)
Duchenne muscular dystrophy (212)
Earnings (63301)
Editorial (59)
Employer branding (18)
Employer resources (138)
Events (98693)
Executive appointments (1032)
FDA (18259)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1458)
Gene editing (201)
Generative AI (44)
Gene therapy (573)
GLP-1 (910)
Government (4716)
Grass and pollen (7)
Guidances (380)
Healthcare (18262)
HIV (56)
Huntington's disease (39)
IgA nephropathy (79)
Immunology and inflammation (223)
Immuno-oncology (53)
Indications (103)
Infectious disease (2939)
Inflammatory bowel disease (186)
Inflation Reduction Act (13)
Influenza (115)
Intellectual property (245)
Interviews (530)
IPO (14915)
IRA (45)
Job creations (3420)
Job search strategy (1947)
JPM (62)
Kidney cancer (17)
Labor market (75)
Layoffs (591)
Leadership (36)
Legal (6478)
Liver cancer (84)
Longevity (12)
Lung cancer (621)
Lymphoma (363)
Machine learning (40)
Management (54)
Manufacturing (743)
MASH (163)
Medical device (13037)
Medtech (13086)
Mergers & acquisitions (18733)
Metabolic disorders (1206)
Multiple sclerosis (150)
NASH (13)
Neurodegenerative disease (302)
Neuropsychiatric disorders (86)
Neuroscience (2785)
Neurotech (1)
NextGen: Class of 2026 (6384)
Non-profit (4350)
Now hiring (21)
Obesity (549)
Opinion (290)
Ovarian cancer (161)
Pain (200)
Pancreatic cancer (223)
Parkinson's disease (273)
Partnered (33)
Patents (495)
Patient recruitment (507)
Peanut (58)
People (61231)
Pharmaceutical (19)
Pharmacy benefit managers (26)
Phase 1 (20830)
Phase 2 (29126)
Phase 3 (21256)
Pipeline (5106)
Policy (271)
Postmarket research (2472)
Preclinical (8855)
Press Release (67)
Prostate cancer (241)
Psychedelics (41)
Radiopharmaceuticals (279)
Rare diseases (818)
Real estate (6039)
Recruiting (66)
Regulatory (22293)
Reports (40)
Research institute (2470)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (15)
RSV (66)
Schizophrenia (144)
Series A (240)
Series B (184)
Service/supplier (8)
Sickle cell disease (94)
Special edition (15)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3378)
State (1)
Stomach cancer (11)
Supply chain (86)
Tariffs (67)
The Weekly (59)
Vaccines (971)
Venture capital (77)
Weight loss (337)
Women's health (81)
Worklife (21)
Date
Last 7 days (569)
Last 30 days (1882)
Last 365 days (28267)
2026 (3260)
2025 (28681)
2024 (32277)
2023 (36343)
2022 (46623)
2021 (51588)
2020 (50744)
2019 (44792)
2018 (34073)
2017 (30709)
2016 (30055)
2015 (35443)
2014 (28380)
2013 (24948)
2012 (26218)
2011 (26457)
2010 (24937)
Location
Africa (886)
Alabama (84)
Alaska (6)
Arizona (238)
Arkansas (14)
Asia (39393)
Australia (7067)
California (10325)
Canada (3068)
China (1053)
Colorado (438)
Connecticut (441)
Delaware (326)
Europe (91827)
Florida (1555)
Georgia (344)
Hawaii (3)
Idaho (59)
Illinois (868)
India (65)
Indiana (473)
Iowa (22)
Japan (410)
Kansas (118)
Kentucky (39)
Louisiana (26)
Maine (74)
Maryland (1271)
Massachusetts (7285)
Michigan (332)
Minnesota (561)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (26)
Nevada (113)
New Hampshire (76)
New Jersey (2872)
New Mexico (30)
New York (2813)
North Carolina (1403)
North Dakota (10)
Northern California (4981)
Ohio (318)
Oklahoma (23)
Oregon (42)
Pennsylvania (2038)
Puerto Rico (24)
Rhode Island (45)
South America (1187)
South Carolina (52)
South Dakota (1)
Southern California (4102)
Tennessee (167)
Texas (1652)
United States (37053)
Utah (319)
Vermont (1)
Virginia (256)
Washington D.C. (66)
Washington State (853)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
666,677 Results for "university of alberta".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Onco-Innovations Attends University of Alberta’s 2025 Innovation Awards
November 26, 2025
·
4 min read
Press Releases
Biosenta to Field-Test Antimicrobial Nanoparticles with Livespace Homes in Alberta Multi-Unit Build
December 11, 2025
·
4 min read
Press Releases
AbbVie’s VRAYLAR® (cariprazine) Now Publicly Reimbursed in Alberta
September 16, 2025
·
4 min read
Press Releases
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
June 16, 2025
·
4 min read
Business
Nanostics Receives Funding from the University of Alberta Innovation Fund to Propel Adoption of the ClarityDX Prostate Test
University of Alberta Innovation Fund invests in Nanostics to support adoption of its ClarityDX Prostate test.
April 23, 2024
·
3 min read
Press Releases
PlasCred Awarded $5 Million Grant from Emissions Reduction Alberta to Advance Neos Facility
July 23, 2025
·
7 min read
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary announce largest donation in Alberta Health Service’s history to the new Calgary Cancer Centre
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary are thrilled to announce a historic and transformational $50 million donation to the Calgary Cancer Centre from the Arthur J.E. Child Foundation.
June 28, 2023
·
7 min read
Press Releases
PlasCred Circular Innovations Inc. Announces Alberta Innovates Funding Grant
April 8, 2025
·
6 min read
Press Releases
Alberta sets a new standard for advanced prostate cancer treatment with public reimbursement of Pluvicto™
March 10, 2025
·
4 min read
Business
Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes
Adhera Therapeutics, Inc. (OTCQB: ATRX) (“Adhera” or the “Company”), a clinical stage biopharmaceutical company, is pleased to announce that the Company is to commence a dose finding study of MLR-1023 (tolimidone) in Type 1 Diabetes in collaboration with the Alberta Diabetes Institute (“ADI”) at the University of Alberta (“U of A”), located in Edmonton, Alberta, Canada.
January 25, 2023
·
6 min read
1 of 66,668
Next
